Evidence map›Paper›PMID 39104091›Full record

ArticleInfluenza and other respiratory viruses2024

Epidemiologic and Virologic Characteristics of Influenza in Lao PDR, 2016-2023.

Natalie Wodniak, KeoOudomphone Vilivong, Bouaphanh Khamphaphongphane, Bounthanom Sengkeopraseuth, Virasack Somoulay, May Chiew, Pakapak Ketmayoon, Melissa Jiao, Sonesavanh Phimmasine, Kim Carmela Co and 7 more

Abstract read
In one paragraph

Article in Influenza and other respiratory viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Natalie WodniakThailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.ORCID 0000-0001-8963-4613
KeoOudomphone VilivongNational Center for Laboratory and Epidemiology, Vientiane, Lao People's Democratic Republic.
Bouaphanh KhamphaphongphaneNational Center for Laboratory and Epidemiology, Vientiane, Lao People's Democratic Republic.
Bounthanom SengkeopraseuthNational Center for Laboratory and Epidemiology, Vientiane, Lao People's Democratic Republic.
Virasack SomoulayNational Center for Laboratory and Epidemiology, Vientiane, Lao People's Democratic Republic.
May ChiewWHO Health Emergencies Programme, World Health Organization, Vientiane, Lao People's Democratic Republic.
Pakapak KetmayoonWHO Health Emergencies Programme, World Health Organization, Vientiane, Lao People's Democratic Republic.
Melissa JiaoWHO Health Emergencies Programme, World Health Organization, Vientiane, Lao People's Democratic Republic.
Sonesavanh PhimmasineWHO Health Emergencies Programme, World Health Organization, Vientiane, Lao People's Democratic Republic.
Kim Carmela CoWHO Health Emergencies Programme, World Health Organization, Vientiane, Lao People's Democratic Republic.
Phetdavanh LeuangvilayWHO Health Emergencies Programme, World Health Organization, Vientiane, Lao People's Democratic Republic.
Satoko OtsuWHO Health Emergencies Programme, World Health Organization, Vientiane, Lao People's Democratic Republic.
Viengphone KhanthamalyU.S. Centers for Disease Control and Prevention Collaboration-Laos, Vientiane, Lao People's Democratic Republic.
Phayvanh KeopaseuthMinistry of Health, Vientiane, Lao People's Democratic Republic.
William W DavisThailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.ORCID 0000-0001-7062-9531
Martha P MontgomeryThailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand.ORCID 0000-0002-9392-9294
Phonepadith XangsayyarathNational Center for Laboratory and Epidemiology, Vientiane, Lao People's Democratic Republic.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundInfluenza sentinel surveillance in Lao PDR is used to inform seasonal vaccination programs. This analysis reviews epidemiologic and virologic characteristics of influenza virus infection over 8 years, before and after emergence of SARS-CoV-2.

methodsData collected for ILI and SARI surveillance during January 2016 through December 2023 were analyzed from nine hospitals. Respiratory specimens from ILI and SARI cases were tested by reverse transcriptase polymerase chain reaction to determine influenza positivity and subtype and lineage. Aggregate counts of outpatient visits and hospitalizations were collected from hospital logbooks. Epidemiologic trends of influenza activity were described, and the proportional contribution of influenza-associated ILI and SARI to outpatient and inpatient loads was estimated.

resultsInfluenza was detected year-round with positivity peaking during September through January and occurring in most years approximately 1 month earlier in the south than the north. After decreasing in 2 years following the emergence of SARS-CoV-2, influenza positivity increased in 2022 and resumed its typical temporal trend. Influenza-associated ILI contribution to outpatient visits was highest among children ages 5-14 years (3.0% of all outpatient visits in 2023), and influenza-associated SARI contribution to inpatient hospitalizations was highest among children ages 2-4 years (2.2% of all hospitalizations in 2023).

conclusionsInfluenza surveillance in Lao PDR provides clinicians and public health authorities with information on geographic and temporal patterns of influenza transmission. Influenza surveillance data support current vaccination timing and recommendations to vaccinate certain populations, especially young children.

Indexed as

HospitalizationInfluenza, HumanSentinel SurveillanceAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCOVID-19FemaleHumansInfantInfant, NewbornLaosMaleepidemiologyhospitalizationhuman influenzareverse transcriptase polymerase chain reactionsentinel surveillancevaccination

Identifiers

PMID39104091
PMCPMC11300510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.